CoreVionRX BPC-157 is 99% purity, verified by HPLC with mass-spectrometry identity confirmation
[DOI] [PubMed] [Google Scholar] 63.Sekhar R.V., Patel S.G., Guthikonda A.P., Reid M., Balasubramanyam A., Taffet G.E., Jahoor F
BPC-157 reverses short bowel syndrome manifestations in animal models, promoting constant weight gain above preoperative values and increasing villus height, crypt depth, and muscle layer thickness in the remaining intestinal tissue
Unlike most peptides, which are rapidly degraded by stomach acid and digestive enzymes, BPC-157 is derived from a protein naturally present in human gastric juice and has demonstrated remarkable resistance to enzymatic hydrolysis in gastric conditions
Find out what this means for hazardous drug management: To view or add a comment, sign in More Relevant Posts Many discussions on DSCSA usually leave out the prescriber side
Pentadecapeptide BPC 157 attenuates colitis in rats